It suggests that these species, which maintain a filovirus infection without negative health consequences, could have selectively maintained these so-called "fossil" genes as a genetic defense. The ...

Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever. Case fatality rates of filovirus disease outbreaks are among the highest reported for any human pathogen ...

Vaccines that induce protective T-cell responses could protect against members across the filovirus family, according to a study published February 28 in the open-access journal PLOS Pathogens by ...

How the human immune system protects against Ebola Date: August 23, 2018 Source: PLOS Summary: 'The current approach for treatment of filovirus infections with antibody cocktails tested in animal ...

Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine. PLOS Pathogens , 2019; 15 (2): e1007564 DOI: 10.1371 ...

The biggest filovirus outbreak, caused by Ebola virus, occurred in three West African countries from 2014 to 2016. It killed more than 11,000 people and infected more than 28,000. More recently, a ...

Soligenix Inc (NASDAQ: SNGX) announced positive preclinical data from its filovirus vaccine candidates, including thermostabilized multivalent vaccines in a single vial platform presentation. Data ...

As of May 26, 2005, the Angolan Ministry of Health had reported 399 cases of Marburg hemorrhagic fever, 335 of which were fatal. Even as this unprecedented spread of filovirus infection continued, ...

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update BARDA Invites Contract Proposal for SuVax™ and MarVax™ Vaccine Candidates On October 27, 2022, Soligenix, Inc ...

A global consortium led by Adaptvac ApS aims to design and test a new vaccine that could offer broad protection against several filoviruses, including Zaire ebolavirus, Sudan ebolavirus and Marburg ...